NEW YORK (GenomeWeb News) – Shares of Exact Sciences rose as much as 7 percent today after Mizuho Securities increased the target price for the colorectal cancer molecular diagnostic firm to $18 from $13.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.